Metabolic control of diabetes is associated with an improved response of diabetic retinopathy to panretinal photocoagulation

Diabetes Care

Volumn 28, Issue 10, 2005, Pages 2454-2457

  Kotoula, Maria G ^a,b   Koukoulis, George N ^a   Zintzaras, Elias ^a   Karabatsas, Constantinos H ^a   Chatzoulis, Dimitrios Z ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMAN; LASER COAGULATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OPHTHALMOSCOPY; PANRETINAL PHOTOCOAGULATION; PROBABILITY; REMISSION; STATISTICAL MODEL;

AGED; ALBUMINURIA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LIGHT COAGULATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 25644435717     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.10.2454     Document Type: Article

References (32)

1. The Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings: DRS report #8. Ophthalmology 88:583-600, 1981
2. Vander JF, Duker JS, Benson WE, Brown GC, McNamara JA, Rosenstein RB: Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation. Ophthalmology 98:1575-1579, 1991
3. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
4. Wang PH, Lau J, Chalmers TC: Metaanalysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 341:1306-1309, 1993
5. Klein R, Klein BE, Moss SE, Cruickshanks KJ: Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 154: 2169-2178, 1994
6. Brownlee M: Glycation and diabetic complications. Diabetes 43:836-841, 1994
7. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL 3rd, Knatterud GL: Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study report #18. Invest Ophthalmol Vis Sci 39:233-252, 1998
8. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105:1801-1815, 1998
9. The LJK Prospective Diabetes Study (UKPDS) Group: Intensive blood- glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998
10. Fong DS, Ferris FL, Davis MD, Chew EY: Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report #24: The Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol 127:137-141, 1999
11. Leese G: Longitudinal study examining the risk for proliferative retinopathy and maculopathy in type 1 diabetes. Eye 18: 814-882, 2004
12. Cruickshanks KJ, Ritter LL, Klein R, Moss SE: The association of microalbuminuria with diabetic retinopathy: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 100:862-867, 1993
13. The Diabetic Retinopathy Study Research Group: Four risk factors for severe visual loss in diabetic retinopathy: the third report from the Diabetic Retinopathy Study. Arch Ophthalmol 97:654-655, 1979
14. The Early Treatment Diabetic Retinopathy Study Research Group: Photocoagulation for diabetic macular edema. ETDRS report #1. Arch Ophthalmol 103:1796-1806, 1985
15. The Early Treatment Diabetic Retinopathy Study Research Group: Results after lens extraction in patients with diabetic retinopathy. ETDRS report #25. Arch Ophthalmol 117:1600-1606, 1999
16. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 21:523-531, 1998
17. Phlynn HW, Smiddy WE: Diabetes and Ocular Disease. San Francisco, CA, American Academy of Ophthalmology, 2000 (monograph no. 14)
18. McCullagh P, Nelder JA: Generalized Linear Models. 2nd Ed. London, Chapman and Hall, 1989
19. Doft BH, Blankenship G: Retinopathy risk factors regression after laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 91: 1453-1457, 1984
20. Bonnardel-Phu E, Vicaut E: Reactive oxygen species and acute modulation of albumin microvascular leakage in the microcirculation of diabetic rats in vivo. J Vasc Res 37:32-38, 2000
21. Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, Hori O, Stern D, Schmidt AM: Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin invest 97:238-243, 1996
22. Tilton RG, Chang K, Pugliese G, Fades DM, Province MA, Sherman WR, Kilo C, Williamson JR: Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 38:1258-1270, 1989
23. Levy AP, Levy NS, Wegner S, Goldberg MA: Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270:13333-13340, 1995
24. Tilton RG, Kawamura T, Chang KC, Ido Y, Bjercke RJ, Stephan CC, Brock TA, Williamson JR: Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest 99:2192-2202, 1997
25. Inagi R, Miyata T, Yamamoto T, Suzuki D, Urakami K, Saito A, van Ypersele de Strihou C, Kurokawa K: Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 463:260-264, 1999
26. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP: Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 101:1219-1224, 1998
27. Wilson AS, Hobbs BG, Wei-Yong Shen, Speed TP, Schmidt U, Begley CG, Rakoczy EP: Argon laser photocoagulation-induced modification of gene expression in the retina. Invest Ophthalmol Vis Sci 44: 1426-1434, 2003
28. Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY: Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci 41:2115-2119, 2000
29. Lip PL, Chatterjee S, Caine GJ, Hope-Ross MW, Gibson JM, Blann AD, Lip GY: Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Br J Ophthalmol 88:1543-1546, 2004
30. Gilbert RE, Tsalamandris C, Bach LA, Panagiotopoulos S, O'Brien RC, Allen TJ, Goodall I, Young V, Seeman E, Murray RM, et al: Long-term glycemic control and the rate of progression of early diabetic renal disease. Kidney M 44:855-859, 1993
31. Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW: Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis 31:947-953, 1998
32. Gilbert RE, Tsalamandris C, Allen TJ, Colville D, Jerums G.: Early nephropathy predicts vision-threatening retinal disease in patients with type 1 diabetes mellitus. J Am Soc Nephrol 9:85-89, 1998